TLPH: Talphera, Inc. Stock

by  •  • Comments Off on TLPH: Talphera, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 16.99
Enterprise Value ($M) 10.10
Book Value ($M) 12.73
Book Value / Share 0.75
Price / Book 1.33
NCAV ($M) 3.91
NCAV / Share 0.23
Price / NCAV 4.34

Profitability (mra)
Return on Invested Capital (ROIC) -0.71
Return on Assets (ROA) -0.59
Return on Equity (ROE) -1.31

Liquidity (mrq)
Quick Ratio 4.90
Current Ratio 4.90

Balance Sheet (mrq) ($M)
Current Assets 16.04
Assets 24.86
Liabilities 12.13
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 4.99 3.01
02-13 13G/A Lind Global Fund II LP 4.20
01-23 13D Nantahala Capital Management, LLC 11.80 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-10-29 5,795 19,677 29.45
2024-10-28 9,873 54,082 18.26
2024-10-25 2,642 19,077 13.85
2024-10-24 27,988 89,757 31.18

(click for more detail)

Similar Companies
TBPH – Theravance Biopharma, Inc. TCRX – TScan Therapeutics, Inc.
TKNO – Alpha Teknova, Inc. TNGX – Tango Therapeutics, Inc.
TRDA – Entrada Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io